Nanofiber-based systems intended for diabetes

J Nanobiotechnology. 2021 Oct 12;19(1):317. doi: 10.1186/s12951-021-01065-2.

Abstract

Diabetic mellitus (DM) is the most communal metabolic disease resulting from a defect in insulin secretion, causing hyperglycemia by promoting the progressive destruction of pancreatic β cells. This autoimmune disease causes many severe disorders leading to organ failure, lower extremity amputations, and ultimately death. Modern delivery systems e.g., nanofiber (NF)-based systems fabricated by natural and synthetic or both materials to deliver therapeutics agents and cells, could be the harbinger of a new era to obviate DM complications. Such delivery systems can effectively deliver macromolecules (insulin) and small molecules. Besides, NF scaffolds can provide an ideal microenvironment to cell therapy for pancreatic β cell transplantation and pancreatic tissue engineering. Numerous studies indicated the potential usage of therapeutics/cells-incorporated NF mats to proliferate/regenerate/remodeling the structural and functional properties of diabetic skin ulcers. Thus, we intended to discuss the aforementioned features of the NF system for DM complications in detail.

Keywords: Cell transplantation; Delivery systems; Diabetic wound; Electrospinning; Nanofiber; Scaffold; Wound dressing.

Publication types

  • Review

MeSH terms

  • Animals
  • Bandages
  • Cell Line, Tumor
  • Diabetes Mellitus / therapy*
  • Diabetic Foot / therapy
  • Drug Delivery Systems*
  • Humans
  • Insulin-Secreting Cells / metabolism
  • Mice
  • Nanofibers*
  • Rats
  • Tissue Engineering*